Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Billing System, 20% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Increased Previous Year's Dividend by 1 yen, This Fiscal Year to Increase Dividend by 3.3 yen
3623 Billing System Corporation 【J-GAAP】
Earnings ReportBilling System Corporation <3623> [TSE Growth] announced its financial results after the market closed on February 14th (15:30). The consolidated ordinary profit for the fiscal year ending December 2024 expanded 34.3% from the previous period to 623 million yen. In the fiscal year ending December 2025, the profit is expected to grow by 19.6% to 745 million yen, marking the second consecutive term of record-high profits. This will be the sixth consecutive term of revenue growth.
At the same time, the company increased the annual dividend for the previous term from 21.5 yen to 22.5 yen (compared to 12 yen in the prior term), and has decided to increase the dividend this fiscal year to 25.8 yen, an increase of 3.3 yen from the previous fiscal year.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit decreased to 181 million yen, a 9.0% decrease compared to the same period last year. The operating profit margin decreased from 19.3% in the same period last year to 16.4%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 3,434 | 481 | 480 | 323 | 51.4 | 10 | Feb 13, 2023 | J-GAAP |
Dec, 2023 | 3,782 | 466 | 464 | 300 | 47.7 | 12 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 4,218 | 626 | 623 | 406 | 64.7 | 22.50 | Feb 14, 2025 | J-GAAP |
YoY | +11.5% | +34.3% | +34.3% | +35.3% | +35.6% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 4,210 | 616 | 614 | 402 | 63.9 | 21.50 | Dec 19, 2024 | J-GAAP |
Dec, 2024 Results | 4,218 | 626 | 623 | 406 | 64.7 | 22.50 | Feb 14, 2025 | J-GAAP |
Revision Rate | +0.2% | +1.6% | +1.5% | +1.0% | +1.2% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 2,080 | 306 | 305 | 199 | 31.7 | 0 | Aug 14, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 14, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 3,782 | 466 | 464 | 300 | 47.7 | 12 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 4,218 | 626 | 623 | 406 | 64.7 | 22.50 | Feb 14, 2025 | J-GAAP |
Dec, 2025 Guidance | 4,794 | 749 | 745 | 464 | 73.8 | 25.80 | Feb 14, 2025 | J-GAAP |
YoY | +13.7% | +19.6% | +19.6% | +14.3% | +14.0% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 1,038 | 200 | 199 | 144 | 22.9 | 19.3 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 995 | 144 | 144 | 94 | 15.1 | 14.5 | May 14, 2024 | J-GAAP |
Apr - Jun, 2024 | 1,085 | 162 | 161 | 105 | 16.7 | 14.9 | Aug 14, 2024 | J-GAAP |
Jul - Sep, 2024 | 1,030 | 138 | 137 | 89 | 14.2 | 13.4 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 1,108 | 182 | 181 | 118 | 18.8 | 16.4 | Feb 14, 2025 | J-GAAP |
YoY | +6.7% | -9.0% | -9.0% | -18.1% | -17.9% |
Related Articles
freee, First Half Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Turns to Profit
NANO MRNA, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows
Kubota Pharma, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
Alpha Purchase, 14% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term, Dividend Raised by 8 yen
AKIKAWA FOODS&FARMS, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 35%
PATH, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Widens, Oct-Dec Ordinary Profit Loss Widens
Agent Insurance Group, 92% Increase in Ordinary Profit, Record High for The First Time in Four Years
Atlas Technologies, Returning to Profitability This Year
JAPAN INSULATION, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 42%, Oct-Dec Ordinary Profit Decreases by 38%
YASUNAGA, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 6% Increase